13 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2198797/reasons-why-hold-strategy-is-suitable-for-slb-stock-right-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2198797
Dec 15, 2023 - SLB forecasts continued sequential revenue growth, and maintains high pretax segment operating and EBITDA margins.
zc:-5035387551287057623
0
https://www.zacks.com/stock/news/2197568/blueprint-bpmc-gets-ec-nod-for-ayvakit-expanded-use-stock-up?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2197568
Dec 13, 2023 - Blueprint (BPMC) announces EC approval expanding Ayvakit's indication to include the treatment of adult patients with indolent systemic mastocytosis. The stock gained 5%.
zc:-8113738612440637649
0
https://www.zacks.com/stock/news/2197343/has-constellation-energy-corporation-ceg-outpaced-other-oils-energy-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2197343
Dec 13, 2023 - Here is how Constellation Energy Corporation (CEG) and Ecopetrol (EC) have performed compared to their sector so far this year.
zc:-7083621467927544755
0